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Abstract
Background: Hepatitis B virus (HBV) genotype and its role in disease progression and patients’ response to antiviral
treatment, is not well studied in Pakistan. This comprehensive study was aimed to determine the distribution of HBV
genotypes in Pakistan and their possible association with phases of HBV infection.
Methods: A total of 840 HBsAg positive samples was collected and tested for HBV DNA quantity. Samples below 100
IU/ml were excluded from the study. A total of 715 samples representing all the six parts of the country were
genotyped by type specific primer PCR method. Clinical data of only 384 patients was compared as the remaining 332
were either receiving antiviral treatment or their infection phase was not confirmed.
Results: Genotype D was found in 509 samples (71.2 %), genotype A in 55 samples (7.7 %) and mixed infection with
genotypes A and D in 124 samples (17.3 %). Genotypes B, C and E were identified in less than 1 % of the total samples.
Genotype A, D and their mixture (A + D) were compared for severity of HBV infection. Significant differences were not
found in distribution of HBV genotypes among different disease stages.
Conclusion: HBV genotype D was the predominant infection in all study areas of Pakistan followed by mixed
genotypes infection (A + D) whereas genotype A has 10 times lower prevalence than genotype D. Genotypes B, C, E
and F altogether make only 1.5 % of the prevalence. Genotype do not appears to show the severity of liver disease.
Keywords: Hepatitis B virus, HBV genotypes, Liver disease progression, PCR
Abbreviations: AJK, Azad Jammu and Kashmir; ANOVA, Analysis of Variance; bp, Base Pairs; ddH2O, Double Distilled
Water; DNA, Deoxy ribo nucleic acid; FATA, Federally Administered Tribal Areas; FCT, Federal Capital Territory;
HBsAg, Hepatitis B Surface Antigen; HBV, Hepatitis B Virus; HCC, Hepatocellular Carcinoma; HEC, Higher Education
Commission; IU/ml, International Unit Per Milli Liter; KP, Khyber Pakhtoonkha; NORI, Nuclear Medicine, Oncology and
Radiotherapy Institute; PCR, Polymerase Chain Reaction; PMAS, Pir Mehr Ali Shah; SPSS, Statistical Package for Social
Sciences; USA, United States of America; °C, Centigrade
Background
Hepatitis B virus (HBV) infection has been a major health
problem as about 400 million people carry hepatitis B sur-
face antigen worldwide [1], out of which, nearly 1 million
die every year [2]. The infection rate of HBV has de-
creased significantly in developed countries like United
States of America [3], where the acute HBV infection rate
has fallen by 78 % during 1990–2005 [4]. Unfortunately,
in developing and underdeveloped countries including
Pakistan, the infection rate seems to have not decreased,
even to any appreciable level. The failure in tackling the
infection has been related to the high cost of antiviral
drugs, lack of vaccination and public awareness about in-
fection and the mismanagement to address the problem
in Pakistan [5].
Eight HBV genotypes have been established on the basis
of 8 % or more nucleotide divergence in the genome.
These genotypes are named as A, B, C, D [6], E, F [7, 8],
G [9] and H [10] which are common [11], while genotype
I [12, 13] and J [14] are also introduced as new genotypes
but their status is questionable. HBV genotypes have spe-
cific pattern of distribution in different geographic regions
and ethnic groups of the world. Genotype A is prevalent
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in Brazil, USA, Canada, Northwest Europe, South Asia,
Central African countries, Tunisia and Benin [15–17].
Genotype B is common in Japan, Taiwan, Philippines,
Hong Kong, China, Vietnam, Thailand, Indonesia and
United States of America. Genotype C occurs in Australia,
Polynesia, Melanesia, Micronesia, Indonesia, China, Hong
Kong, Vietnam, Thailand, Japan, Korea, Taiwan, India,
Solomon Islands, Brazil and USA. Genotype D is predom-
inant in Mediterranean region, Spain, Albania, Czech
Republic, Russia, Turkey, Middle East, Iran, Afghanistan,
South Asia, Solomon Islands, Tunisia, Polynesia,
Melanesia, Micronesia, Brazil and USA [17–19]. Genotype
E is endemic to Africa where it occurs only in some coun-
tries of the Western part of the continent while genotype
F is widely distributed in new world. It has been reported
from Alaska, Argentina, South America, Central America
and Polynesia [17, 20]. Genotypes G has been recorded
from North America, France and Germany, genotype H
from Central America, South America and Mexico while
genotypes I and J were reported only from Vietnam and
Japan respectively [17].
HBV genotypes have been reported to have significant
association with progression of liver diseases, risk of cir-
rhosis, development of hepatocellular carcinoma (HCC),
viral load, HBsAg sero-clearance, HBeAg sero-conversion
and response to antiviral therapy [21]. Co-infection with
two different virus genotypes has been reported to be as-
sociated with worse prognosis of the disease. Some studies
showed that co-infection with HBV/B and HBV/C is asso-
ciated with high viral load and more severe liver disease as
compared to single genotype infection [22, 23]. The pa-
tients with HBV/A have been reported to be more sensi-
tive to interferon α treatment as compared to those
infected with HBV/D [24] while the patients having infec-
tion with HBV/B have a higher response rate to interferon
α treatment as compared to the patients infected with
HBV/C [25]. Moreover, infection with genotype C alone
was also found to be associated with significantly higher
risks of liver cirrhosis and hepatocellular carcinoma as
compared to genotype B infection [26, 27] while HBV/B
shown an earlier HBsAg sero-clearance rate as compared
to HBV/C [28]. In another study, HBV/A was found to
have significantly higher sero-conversion rate of HBeAg as
compared to HBV/B, HBV/C, HBV/D and HBV/F [29].
From all the studies mentioned above it’s quite clear that
genotypes influence disease condition as well as response
to treatment.
The picture regarding distribution of HBV genotypes
in Pakistan and its association with disease stage has not
been clearly understood yet. In fact, all of the available
studies are mostly confined to specific cities/areas like
Karachi (Sind) and Lahore (Punjab) and none of them
contain data from other parts of the country. A vast
range of areas from different regions of Pakistan still
remains unexplored for HBV genotypes. Moreover, the
existing state of knowledge regarding the distribution
and prevalence of HBV genotypes in Pakistan seems to
be sketchy and questionable too. For example, four stud-
ies [5, 30–32] are in agreement that genotype D infec-
tion is most prevalent in the country while three studies
[18, 33, 34] reported that genotype C is the most com-
mon ones in Pakistan. Yet in an another study, genotype
C and D have been cited as most common HBV geno-
types in Pakistan [35]. In view of the presence of the in-
adequate data, it was felt that a comprehensive study is
required to determine the current distribution of HBV
genotypes in all the six provinces of Pakistan and their




Eight hundred and forty (840) samples from HBsAg posi-
tive patients were collected during October 2010 to March
2013 from different locations of six regions of Pakistan
which include Punjab and Federal Capital Territory of
Islamabad (n = 359); Khyber Pakhtoonkhwa along with
Federally Administered Tribal Areas (n = 115); Azad
Jammu and Kashmir (n = 81); Gilgit-Baltistan (n = 111);
Sind province including Karachi city (n = 107); and
Baluchistan (n = 67). The sampling sites and the details of
patients are given in Fig. 1 and Table 1 respectively. All
the patients were diagnosed as chronic HBV carriers.
Serum samples were acquired from the different hospitals
and diagnostic laboratories of the above regions where
they were originally collected for routine diagnostic pur-
poses. All the available data of clinical and demographic
importance were collected at the time of sample collection
by filling out a questionnaire. All the samples were then
brought to Nuclear Medicine, Oncology and Radiotherapy
Institute (NORI), Islamabad and stored at −25 °C for
further analysis. The samples were tested for positivity
and quantity of HBV DNA. Only the samples having more
than 100 IU/ml of viral load were subjected to HBV geno-
typing (Table 1). The samples with lower than 100 IU/ml
of viral load were excluded because their genotyping was
not successful in most of the cases. All the routine tests
including HBsAg, ALT, and anti-HBe were performed in
Central Laboratories, NORI using commercially available
kits (Abott Diagnostics, USA).
The stage of HBV infection was primarily assigned by
the local physician and further confirmed by the status
of different HBV markers and biochemical tests. Only
384 patients were included in the study of genotypes in-
fluence on disease stage. All the patients (331) who had
already received antiviral treatment or had co-infection
with HIV, HCV or HDV were excluded from this part of
study. The liver disease stage was primary assigned by
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classified gastroenterologists and then the disease phase
was further confirmed on the base of patients’ HBV viral
load, ALT levels, HBeAg status and the presence or ab-
sence of anti HBe antibodies (Table 3). The study was
approved by institutional ethics committee of PMAS
Arid Agriculture University Rawalpindi and each patient
gave written consent.
HBV DNA extraction and quantification
HBV DNA was extracted from the plasma according to
manufacturer’s protocol using “Instant Virus DNA kit” (AJ
Roboscreen, Analytikajena Biosolutions, GmbH, Germany)
while the DNA was quantified using RoboGene® HBV Quan-
tification kit (AJ Roboscreen, analytikajena Biosolutions,
GmbH, Germany) according to manufacturer’s instructions.
HBV genotyping
The genotyping was performed using PCR method with
genotype specific primers described by Naito et al. [36]
with some modifications in cycling profile and PCR con-
stituents. For regular PCR, 10 μl of GoTaq® Green Master
mix (Promega, USA), 1 μl each of universal primers P1A
Table 1 Samples collected and selected for HBV genotyping from different regions of the country
Total no of samples (No of male and female samples)
Punjab and FCT KP and FATA AJK Gilgit-Baltistan Sind Baluchistan Total
Total collected 359 (243 + 116) 115 (78 + 37) 81 (50 + 31) 111 (83 + 28) 107 (68 + 39) 67 (39 + 28) 840 (561 + 279)
Negative HBV DNA 29 (18 + 11) 7 (5 + 2) 6 (4 + 2) 8 (6 + 2) 13 (7 + 6) 6 (4 + 2) 69 (44 + 25)
<100 IU/ml 19 (11 + 8) 9 (6 + 3) 7 (4 + 3) 10 (6 + 4) 10 (7 + 3) 1 (0 + 1) 56 (34 + 22)
Total Genotyped 311 (214 + 97) 99 (67 + 32) 68 (42 + 26) 93 (71 + 22) 84 (54 + 30) 60 (35 + 25) 715 (483 + 232)
Abbreviations: FCT federal capital territory, KP Khyber Pkhtoonkhwa, FATA federally administered tribal areas, AJK Azad Jammu and Kashmir
Fig. 1 The map shows the sampling sites in all regions of Pakistan. Sites are indicated with numerals. Sites: 1. Mirpur; 2. Kotli; 3. Palandari; 4. Rawalakot;
5. Bagh; 6. Kahuta; 7. Muzaffarabad; 8. Neelum; 9. Astor; 10. Sikardu; 11. Diamir; 12. Gilgit; 13. Hunza; 14. Chitral; 15. Dir; 16. Swat; 17. Kohistan; 18. Batgram;
19. Mansehra; 20. Abottabad; 21. Haripur; 22. Nowshera; 23. Mardan; 24. Peshawar; 25. Kohat; 26. Hangu; 27. Bannu; 28. LakkiMarwat; 29. D I Khan;
30. Wana; 31. Parachinar; 32. Islamabad; 33. Rawalpindi; 34; Chakwal; 35. Jhelum; 36. Gujrat; 37. Sialkot; 38. Gujranwala; 39. Sargodha; 40. Mianwali;
41. Bhakkar; 42. Jhang; 43. Faisalabad; 44. Lahore; 45. Sahiwal; 46. Multan; 47. D.G. Khan; 48. Bahawalpur; 49. Rahim Yar Khan; 50. Sukhar; 51. Khairpur;
52. Nawabshah; 53. Hyderabad; 54. Mirpur Khas; 55. Karachi; 56. Turbat; 57; Khuzdar; 58. Sibi; 59. Loralai; 60. Quetta. Regions: 1–8, Azad Jammu & Kashmir;
9–13, Gilgit-Baltistan; 14–31, Khyber Pakhtunkhwa; 32, Federal Capital Territory of Islamabad (FCT); 33–49, Punjab; 50–55, Sind; 56–60, Baluchitan
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and S1-2, 2 μl of ddH2O and 6 μl of diluted template
(DNA) were used to make 20 μl of reaction volume. The
thermal profile was; 10 min at 95 °C, then 30 cycles of;
94 °C for 20 s, 55 °C for 20 s and 72 °C for 1 min, then an-
other 7 min at 72 °C (ABI 9700, USA). Two mixes were
used in nested PCR. Mix 1 had the forward primers for
genotype A, B and C with a common reverse primer while
mix two had reverse primers for genotypes D, E and F
with common forward primer. Two μl of product from
1st round of PCR were added to each mix as DNA
template with 8 μl of GoTaq® Green Master mix, 8 μl of
ddH2O and 1 μl of each primer to make 22 μl of final
volume. The cycling profile for nested PCR was; 95 °C for
10 min, then 40 cycles of 94 °C for 45 s, 63 °C for 20 s,
and 72 °C for 60 s, and then another 7 min at 72 °C (ABI
9700, USA). Products were run on 2 % agarose gel which
was stained in a solution of ethidium bromide, and then
observed under ultraviolet fluorescence (BioRad Gel Doc-
XR, USA). Amplified products in mix 1 were 68 bp,
281 bp and 122 bp in size for genotypes A, B and C
respectively while the product sizes in mix 2 were 119 bp,
167 bp and 97 bp for genotypes D, E and F respectively.
The product’s size was estimated with reference to a 50-
bp DNA ladder (GeneRuler™ Fermentas) and the genotype
was determined for each sample according to the sizes of
DNA product obtained in both mixes (Fig. 2). The term
untypable was assigned to those samples which had higher
than 100 IU/ml of viral load but were not successfully
genotype or their genotype was not identified by the
method.
Statistical analysis
Chi square test was applied to evaluate the relationship
HBV genotype and HBV infection phase with each other
as well as with patients’ gender while one way analysis of
variance (ANOVA) was performed to analyze the rela-
tionship of HBV genotype and HBV infection phase with
the age of patients. A value of p less than 0.05 was con-
sidered as statistically significant. SPSS version-16.0 was
used for all the analyses.
Results
Out of total 840 samples, 125 were excluded from the
study as HBV DNA was not detected in them. The
remaining 715 samples were further analyzed (Table 1).
Regional distribution of HBV genotypes
Out of the 715 samples taken for genotyping, 699 were
successfully genotyped while 16 (2.2 %) remained untyp-
able. HBV genotypes A, B, C, D and E were detected in 55
(7.7 %), 4 (0.6 %), 6 (0.8 %), 509 (71.2 %) and 1 (0.1 %) sam-
ples respectively (Table 2). A total of 124 (17.3 %) patients
were infected with more than one genotype i.e. mix geno-
type infection. The mix genotype infection comprised six
combinations in different proportions which were - A + B
(0.3 %), A +D (13.7 %), B +D (1.9 %), C +D (1.0 %), E +D
(0.1 %) and A + B +D (0.3 %).
Concerning the regions included in this study, geno-
type D was always the predominant one with the preva-
lence ranging from 63.3 to 88.3 % (Table 2). Genotype A
and the mix genotype combination A + D was also
present in all regions. The prevalence of genotype A, D
and mix genotypes respectively was 10 %, 63.3 % and
23.5 % in Punjab and FCT region; 7 %, 68 % and 18 % in
KP and FATA region; 4.4 %, 82.3 % and 11.8 % in AJK
region; 3.2 %, 80.6 % and 12.8 % in Gilgilt-Baltistan
region; 10.7 %, 72.6 % and 13 % in Sind region; 3.3 %,
88.3 % and 5 % in Baluchistan region (Fig. 3).
Multiple genotype infections presented the second more
prevalent group of genotypes with 17.3 % of the total sam-
ples infected with 6 different combinations of genotypes
(Table 2). Mix infection with A +D genotype was the
major combination found among multiple genotype infec-
tions which was 98/124 of the samples. Other mix geno-
type combinations identified were B +D, C +D, A + B, A +
B +D and E +D which were 1.9 %, 1.0 %, 0.3 %, 0.3 % and
0.1 % of the samples respectively. None of the combina-
tions except A +D was found in more than 2 % of the
samples. This combination was detected from all parts of
the Pakistan, though it was highest in Punjab and FCT
region (21.8 %) as compared to all other parts (Table 2).
Distribution HBV genotypes in different phases of disease
All statistical comparisons performed for genotypes A, D
and A +D as the other genotypes and their combinations
in mix infections were rare (Table 2). Out of total 715
patients included in the study, 331 (46.3 %) had either
already received antiviral treatment or had co-infection
with HIV, HCV or HDV or had genotype other than A
and D. Thus the remaining 384 (53.7 %) patients who
were not exposed to any treatment till the time of sample
Fig. 2 Amplified PCR products on 2 % gel showing bands for four
genotypes. Lanes 2, 4, 6, 8, 10, 12, 14 and 16: the product bands of
mix 1. Lanes 3, 5, 7, 9, 11, 13, 15 and 17: the product bands of mix 2.
Lanes 1 and 18: 50 bp DNA ladder. lanes 2 + 3: genotype D. lanes 4
+ 5: genotype A. lanes 6 + 7: genotype A + D. lanes 8 + 9: genotype
A + B + D. lanes 10 + 11: genotype C and a nonspecific band. lanes
12 + 13: genotype B + D. lanes 14 + 15: genotype A. lanes 16 + 17;
Genotype A + D
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Table 2 Distribution of HBV genotypes and their combinations in the samples taken from different regions of Pakistan. The numbers
and proportions (%) are given against each genotype or the genotypic combination
Genotype KP and FATA AJK Gilgit-Baltistan Sind Punjab and FCT Baluchistan Total
A 7 (7) 3 (4.4) 3 (3.2) 9 (10.7) 31 (10) 2 (3.3) 55 (7.7)
B 2 (2) 0 1 (1.1) 0 1 (0.3) 0 4 (0.6)
C 3 (3) 1 (1.5) 0 0 1 (0.3) 1 (1.7) 6 (0.8)
D 67 (68) 56 (82.3) 75 (80.6) 61 (72.6) 197 (63.3) 53 (88.3) 509 (71.2)
E 0 0 0 1 (1.2) 0 0 1 (0.1)
Mix 18 (18) 8 (11.8) 11 (12.8) 11 (13) 73 (23.5) 3 (5) 124 (17.3)
A + B 2 (2.0) 0 0 0 0 0 2 (0.3)
A + D 9 (9.1) 5 (7.3) 4 (4.3) 9 (10.7) 68 (21.8) 3 (5.0) 98 (13.7)
B + D 2 (2.0) 0 6 (6.4) 2 (2.3) 4 (1.3) 0 14 (1.9)
C + D 4 (2.0) 3 (4.4) 0 0 0 0 7 (1.0)
E + D 0 0 0 0 1 (0.3) 0 1 (0.1)
A + B + D 1 (1.0) 0 1 (1.1) 0 0 0 2 (0.3)
Untypable 2 (2.0) 0 3 (3.2) 2 (2.3) 8 (2.5) 1 (1.7) 16 (2.2)
Total 99 68 93 84 311 60 715
Fig. 3 Genotype prevalence of hepatitis B virus in all regions of the country. UT stands for un-typable and mix means all the infections with more
than one genotypes
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collection were classified in four different phases of liver
disease: 56 (14.6 %) were in immune control phase, 89
(23.2 %) in immune tolerant phase, 153 (39.8 %) in im-
mune clearance phase and 86 (22.4 %) in immune escape
phase (Table 3). None of the patients had liver cirrhosis or
hepatocellular carcinoma in this study. The mean age of
the patients and gender ratio was statistically equal among
all the disease phases. Genotype D (n = 279) was the most
prevalent in all groups of patients with 36 patients in
immune control group, 67 in immune tolerant group, 112
in immune clearance and 64 in immune escape group.
The second more prevalent was the mix infection A +D
(n = 62) with 13, 12, 26 and 11 cases in immune control,
immune tolerant, immune clearance and immune escape
groups respectively. Genotype A (n = 43) was the least
prevalent with 7, 10, 15 and 11 cases in immune control,
immune tolerant, immune clearance and immune escape
phases respectively. The differences in distribution of ge-
notypes in disease phases were not statistically significant.
Similarly, there were no statistical differences of age
and gender among the three genotype groups compared
(Table 3).
Discussion
The present study is the first of its kind which included
a cohort of 715 patients with chronic HBV infection
from all six regions of Pakistan. The study analyzed the
patients for HBV genotypes and their possible associa-
tions with liver disease severity in 384 consecutive
chronic HBV carriers. According to the results, geno-
types A, B, C, D, E and mix genotype infections with 6
different genotypic combinations are present in Pakistan,
but the majority of patients (92.6 %) were infected with
either genotype D, or genotype A or a mixture of both
(A + D). The pre-dominant genotype in all regions was
D followed by genotype A and mix genotype infection
with A + D. Genotypes B, C, E and F were rare and
collectively form only 1.5 % of the total prevalence.
HBV genotypes were not studied exclusively from all
over the Pakistan so far. Table 4 summarizes some avail-
able data on the topic from Pakistan along with the
results of present study. Most of the available data are
from Karachi and Lahore or Punjab and Sind while none
of the study has explored the regions of FATA, Gilgit-
Baltistan, AJK, some parts of Khyber Pakhtoonkha prov-
ince and most of the Baluchistan province. Though three
studies carried out by Awan et al. [18], Alam et al. [30]
and Idrees et al. [34] investigated the provinces of KP
and Baluchistan additionally but the number of samples
taken were not satisfactory to conclude the genotype
distribution in these provinces (Table 4). None of the
studies included the regions of Gilgit-Baltistan, AJK and
FATA. Two of these three [18, 34] studies reported
genotype C as predominant while one [30] found geno-
type D as predominant one. Genotype B which was not
reported from Pakistan in any other study has also been
reported in all three of these studies from 18 to 25 % of
the samples. These results are contradictory to these
studies.
All the studies confined to the samples from Punjab
and Sind reported genotype D as predominant except
one [33] which reported prevalence of genotype C and
D as 75 and 25 % respectively. The remaining six studies
[5, 31, 32, 37–39] reported genotype D as the common-
est one in Pakistan with percentage distribution of 59,
84, 70, 98.2, 84 and 93.2 % respectively (Table 4). The re-
sults of present study representing all parts of the coun-
try with significant number of samples is in agreement
with the later group [5, 31, 32, 37–39] that reported
genotype D as the most prevalent HBV genotype in
Pakistan. Genotype A was found to be the second more
prevalent single genotype infection with 7.7 %. Genotype
A was also reported in most of the previous studies
[5, 18, 30, 32, 34, 39] in different proportions ranging from
0.8 to 21.4 % and a mean prevalence of 11.7 % (Table 4).
Genotype B was present only in 0.6 % of present study
samples while it was reported in proportions ranging
from 18 to 24.5 % by previous studies from Pakistan
[18, 30, 34]. None of the other studies reported genotype
B infection, however mix infections involving genotype B
were reported by some studies [18, 30, 31, 38] as high as
16 % of the samples (Table 4). Genotype C was detected
Table 3 Characteristics of patients infected with different HBV genotypes (n = 384)
Characteristics Genotype A Genotype D Genotype A + D Sig.
Number of patients (%) 43 (11.2) 279 (72.7) 62 (16.1)
Age (Mean ± SD) 32.4 ± 11.7 34.1 ± 12.1 35.1 ± 12.8 NSa
Gender (M/F) 32/11 202/77 40/22 NSb
Immune Control (N = 56) normal ALT, HBeAg negative, anti HBe positive, low viral load 7 (16.3 %) 36 (12.9 %) 13 (21.0 %) NSb
Immune Tolerant (N = 89) normal ALT, HBeAg positive, anti HBe negative, high viral load 10 (23.2 %) 67 (24.0 %) 12 (19.3 %) NSb
Immune Clearance (N = 153) elevated ALT, HBeAg positive, high viral load 15 (34.9 %) 112 (40.1 %) 26 (41.9 %) NSb
Immune Escape (N = 86) Normal or elevated ALT, HBeAg negative, anti HBe positive,
High HBV DNA,
11 (25.6 %) 64 (22.9 %) 11 (17.7 %) NSb
aOne way Analysis of Variance, bPearson Chi Square Test, NS for non significant
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Table 4 The prevalence of different HBV genotypes in our study compared to previously published studies
Source Place of sampling Sample size Proportion of genotype as percent of total samples
A B C D E F Mix Mixed combinations UT
Hanif et al., 2013 [5] Karachi, Islamabad/Rawalpindi 200 (40, 160) 10 - - 59 - - 31 A + D -
Awan et al., 2010 [18] Punjab, KP, Sind, Baluchistan 300 (222, 36, 26, 15) 14 18 28 13 0.6 1.3 16 A + B + D, A + D + F, A + C, A + D, A + E, A + F,
B + C, B + E, C + D
10.3
Ahmed et al., 2009 [39] Punjab, Sind 236 0.8 - 5.9 93.2 - - - - -
Baig et al., 2009 [32] Karachi 315 20 - - 70 - - 10 A + D -
Noorali et al., 2008 [31] Karachi 180 - - - 84 - - 16 B + D -
Hakim et al., 2008 [38] Karachi 180 - - - 84 - - 16 B + D -
Alam et al., 2007 [30] Punjab, KP, Sind Baluchistan 110 (30, 28, 25, 18) 4.5 24.5 - 60 - - 2.7 A + D, B + D 8.2
Abbas et al., 2006 [37] Karachi 109 - - - 98.2 - - 1.8 A + D -
Idrees et al., 2004 [34] Punjab, KP, Sind Baluchistan 112 (Details not available) 21.4 17.9 41.1 8.0 - - 7.1 Details not available 4.5
Naaz, 2001 [33] Lahore 12 - - 75 25 - - - - -
This study Punjab, KP, Sind, Baluchistan, AJK, Gilgit-Baltistan 715 (311, 99, 84, 60, 68, 93) 7.7 0.6 0.8 71.2 0.1 - 17.3 A + D, B + D, C + D, A + B, A + B + D, E + D 2.2














in only 0.8 % of the samples in our study while three pre-
vious studies [18, 33, 34] have reported it as predominant
genotype in Pakistan, whereas one study [39] reported it
as second more prevalent genotype in the country. Geno-
type C was not reported by any of the other six studies
(Table 4). Genotype E and F were not reported by any
previous study except [18] which reported them in the
proportions of 0.6 and 1.3 %. As already mentioned, geno-
types E and F are endemic to Africa and the New World
respectively [17, 20] and the fact that they were found in
only 1 case (genotype E) was quite expected. Present study
thus supports the conclusion that not only genotypes E
and F but also genotypes B and C were rare in Pakistan
(Table 4).
The relationship of HBV genotypes with liver disease is
still not very clear. Although some studies have reported
that HBV genotype influence the severity of liver disease
and course of chronic HBV infection [26, 28, 40–44].
Some other studies showed that HBV genotype had no
influence on course of HBV infection [43, 45, 46]. Present
study is in concordance with the later group [43, 45, 46].
Most of the studies compared genotype B and C in Asia
and reported that the latter is more associated to severe
liver disease than the former. On the other hand the geno-
type B is associated with an early HBeAg sero-conversion,
more sustained remission after HBeAg sero-conversion,
less active hepatic necroinflammation, a slower rate of
progression to cirrhosis, and a lower rate of hepatocellular
carcinoma (HCC) development as compared to genotype
C [26, 28, 41, 43, 44]. A study from Pakistan compared
genotype A, D and A +D for their association with com-
plex liver diseases and concluded that genotype A is asso-
ciated with more complex liver disease [47]. However,
present study did not find any association of genotypes
with disease stage. The relatively high prevalence of mix
infection with genotypes A +D is a confirmation of the
data reported by several previous findings about HBV
genotyping in Pakistan [5, 18, 30, 32, 34, 37].
Conclusions
In conclusion, it has been observed in the present study
that the distribution of HBV genotypes was almost simi-
lar in all the regions of Pakistan. Genotype D was the
most common one (71.2 %) followed by mix infection
with genotypes A and D (17.3 %) and genotype A
(7.7 %). Although genotypes B, C, E and F were also de-
tected but their prevalence was very low (1.5 %). Fur-
thermore, genotype was not found to have any
significant influence on liver disease progression in
Pakistan.
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